Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial
Jessica E. Manning, Fabiano Oliveira, Iliano V. Coutinho-Abreu, Samantha Herbert, Claudio Meneses, Shaden Kamhawi, Holly Ann Baus, Alison Han, Lindsay Czajkowski, Luz Angela Rosas, Adriana Cervantes-Medina, Rani Athota, Susan Reed, Allyson Mateja, Sally Hunsberger, Emma L. James, Olga Pleguezuelos, Gregory Stoloff, Jesús G. Valenzuela, Matthew J. Memoli
Topics & Concepts
ImmunogenicityMedicinePlaceboVaccinationSalivaAdjuvantClinical endpointClinical trialRandomized controlled trialImmunologyInternal medicineImmune systemPathologyAlternative medicineMosquito-borne diseases and controlInvertebrate Immune Response MechanismsVector-borne infectious diseases